Gelclair® is the company's third commercialized prescription product
Oral mucositis, also called "chemo mouth," a painful inflammation of the mouth's mucous membranes, has emerged as the most significant adverse event in oncology according to a National Comprehensive Cancer Network task force
Severe mucositis/pharyngitis occurred in 70% of head and neck cancer patients in third-party study
Read MoreReed financing expected to be finalized in November 2024
Continued progress towards groundbreaking of Infinite LoopTM India manufacturing facility on schedule
Loop management to hold update call at 8:30 AM ET on October 16, 2024
Read More
